iSOFT Installs e-Prescribing at University Hospitals of Leicester

iSOFTiSOFT, a CSC company, has completed an initial implementation of its e-prescribing and medicines administration solution (ePMA) at the University Hospitals of Leicester NHS Trust, under moves to transform patient safety, clinical outcomes and operational performance.

The project was completed in five months, with the first phase focusing on the bone and marrow transplant unit, oncology and haematology wards, ahead of a roll-out across all wards and departments at the trust's three main hospitals.

The project follows an agreement in June that included iSOFT's ePMA and i.Pharmacy products. This gives Leicester a complete prescribing and medicines management solution to improve dispensing, stock control and further promote medicines good practice across the trust.

"With new and complex medicines being introduced almost on a daily basis, the risk of adverse interactions and clinical errors has increased exponentially," said Beverly Collett, the trust's associate medical director. "Given the sheer volume and complexity of drug information, it is impossible for prescribers to recall all of the potential interactions and their clinical significance. iSOFT's ePMA will support our clinical teams by improving communication and clarity of information, while reducing process complexities that can introduce clinical risk."

The trust is a long standing customer and uses a host of iSOFT patient, clinical and departmental solutions. "This is a clear sign that University Hospitals of Leicester continues to derive genuine value from its partnership with iSOFT," said Adrian Stevens, managing director of iSOFT's UK and Ireland business. "These latest innovations will allow it to build on systems that are familiar and trusted to further improve efficiency and deliver tangible benefits to patients."

iSOFT ePMA provides new opportunities to improve the communication of medicines related information between medical, nursing and clinical pharmacy teams. Advanced drug formulary management, underpinned by clinical and workflow based decision support, provides a highly effective environment to help improve a hospital's performance in relation to medicines. In-built reporting and data analysis tools provide executive and management visibility of performance to help proactively address areas of concern or promote good practice.

Proven at large acute and specialist hospitals in Australia and New Zealand, iSOFT ePMA is shown to halve adverse medication errors that can prolong a patient's stay by up to four days, and so block hospital beds and increase costs.

Related news articles:

About CSC
CSC is a global leader in providing technology-enabled business solutions and services. Headquartered in Falls Church, Va., CSC has approximately 97,000 employees and reported revenue of $16.2 billion for the 12 months ended September 30, 2011.

Most Popular Now

Stepping Hill Hospital Announced as SPAR…

Stepping Hill Hospital, part of Stockport NHS Foundation Trust, has replaced its bedside units with state-of-the art devices running a full range of information, engagement, communications and productivity apps, to...

DMEA 2025: Digital Health Worldwide in B…

8 - 10 April 2025, Berlin, Germany. From the AI Act, to the potential of the European Health Data Space, to the power of patient data in Scandinavia - DMEA 2025...

Is AI in Medicine Playing Fair?

As artificial intelligence (AI) rapidly integrates into health care, a new study by researchers at the Icahn School of Medicine at Mount Sinai reveals that all generative AI models may...

New System for the Early Detection of Au…

A team from the Human-Tech Institute-Universitat Politècnica de València has developed a new system for the early detection of Autism Spectrum Disorder (ASD) using virtual reality and artificial intelligence. The...

Generative AI's Diagnostic Capabili…

The use of generative AI for diagnostics has attracted attention in the medical field and many research papers have been published on this topic. However, because the evaluation criteria were...

Diagnoses and Treatment Recommendations …

A new study led by Prof. Dan Zeltzer, a digital health expert from the Berglas School of Economics at Tel Aviv University, compared the quality of diagnostic and treatment recommendations...

AI Tool can Track Effectiveness of Multi…

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed by UCL researchers. AI uses...

Surrey and Sussex Healthcare NHS Trust g…

Surrey and Sussex Healthcare NHS Trust has marked an important milestone in connecting busy radiologists across large parts of South East England, following the successful go live of Sectra's enterprise...

Dr Jason Broch Joins the Highland Market…

The Highland Marketing advisory board has welcomed a new member - Dr Jason Broch, a GP and director with a strong track record in the NHS and IT-enabled transformation. Dr Broch...

DMEA 2025 Ends with Record Attendance an…

8 - 10 April 2025, Berlin, Germany. DMEA 2025 came to a successful close with record attendance and an impressive program. 20,500 participants attended Europe's leading digital health event over the...

Multi-Resistance in Bacteria Predicted b…

An AI model trained on large amounts of genetic data can predict whether bacteria will become antibiotic-resistant. The new study shows that antibiotic resistance is more easily transmitted between genetically...

AI-Driven Smart Devices to Transform Hea…

AI-powered, internet-connected medical devices have the potential to revolutionise healthcare by enabling early disease detection, real-time patient monitoring, and personalised treatments, a new study suggests. They are already saving lives...